Barnes E - Search Results

1

Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003-2005.

Halliday JS, Harrison GL, Brown A, Hunter JG, Bendall R, Penny D, Toatu T, Abdad MY, Klenerman P, Barnes E, Dalton HR. Halliday JS, et al. Among authors: barnes e. Emerg Infect Dis. 2014 Jun;20(6):1057-8. doi: 10.3201/eid2006.130562. Emerg Infect Dis. 2014. PMID: 24856799 Free PMC article. No abstract available.

2

T cell failure in hepatitis C virus infection.

Barnes E, Lauer G, Walker B, Klenerman P. Barnes E, et al. Viral Immunol. 2002;15(2):285-93. doi: 10.1089/08828240260066233. Viral Immunol. 2002. PMID: 12081013 Review. No abstract available.

3

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.

Barnes E, Harcourt G, Brown D, Lucas M, Phillips R, Dusheiko G, Klenerman P. Barnes E, et al. Hepatology. 2002 Sep;36(3):743-54. doi: 10.1053/jhep.2002.35344. Hepatology. 2002. PMID: 12198669

4

Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.

Kantzanou M, Lucas M, Barnes E, Komatsu H, Dusheiko G, Ward S, Harcourt G, Klenerman P. Kantzanou M, et al. Among authors: barnes e. Immunol Lett. 2003 Jan 22;85(2):165-71. doi: 10.1016/s0165-2478(02)00224-9. Immunol Lett. 2003. PMID: 12527224

5

Boosting immunity by antiviral drug therapy: a simple relationship among timing, efficacy, and success.

Komarova NL, Barnes E, Klenerman P, Wodarz D. Komarova NL, et al. Among authors: barnes e. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1855-60. doi: 10.1073/pnas.0337483100. Epub 2003 Feb 6. Proc Natl Acad Sci U S A. 2003. PMID: 12574516 Free PMC article.

6

Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.

Torti C, Barnes E, Quiros-Roldan E, Puoti M, Carosi G, Klenerman P. Torti C, et al. Among authors: barnes e. Antivir Ther. 2004 Feb;9(1):139-42. Antivir Ther. 2004. PMID: 15040546 No abstract available.

7

Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells.

Barnes E, Ward SM, Kasprowicz VO, Dusheiko G, Klenerman P, Lucas M. Barnes E, et al. Eur J Immunol. 2004 Jun;34(6):1570-7. doi: 10.1002/eji.200424898. Eur J Immunol. 2004. PMID: 15162426 Free article.

8

T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors.

Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. Semmo N, et al. Among authors: barnes e. Lancet. 2005 Jan 22-28;365(9456):327-9. doi: 10.1016/S0140-6736(05)17787-3. Lancet. 2005. PMID: 15664228

9

Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection.

Barnes E, Gelderblom HC, Humphreys I, Semmo N, Reesink HW, Beld MG, van Lier RA, Klenerman P. Barnes E, et al. J Infect Dis. 2009 Mar 15;199(6):819-28. doi: 10.1086/597072. J Infect Dis. 2009. PMID: 19434929

10

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.

Humphreys I, Fleming V, Fabris P, Parker J, Schulenberg B, Brown A, Demetriou C, Gaudieri S, Pfafferott K, Lucas M, Collier J, Huang KH, Pybus OG, Klenerman P, Barnes E. Humphreys I, et al. Among authors: barnes e. J Virol. 2009 Nov;83(22):11456-66. doi: 10.1128/JVI.00884-09. Epub 2009 Sep 9. J Virol. 2009. PMID: 19740991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,442 results

Search Page

Filters